BAT is conducting a new study with Vel that aims to compare modern oral nicotine pouch products with traditional cigarettes, in order to provide new insights into their health impacts. Details of the protocol for this study have been published in the JMIR Research Protocols journal.
The study assessed early indicators related to exposure to certain toxins and smoking-related diseases in individuals who have been using Velo for over six months and compared them to smokers, former smokers, and never smokers.
Currently, the results are being analyzed and will be released before the end of the year.
The modern oral nicotine pouch is an exciting product category, built upon widespread scientific evidence previously used for nasal snuff but designed to offer adult consumers an improved, smoke-free and lower-risk alternative," said Sharon Goodall, Head of Regulatory Science at British American Tobacco.
Our generated data shows that Velo's toxicity characteristics are better than snuff and comparable to nicotine replacement therapies. However, we hope to produce further evidence to prove its significant contribution to reducing tobacco harm. I believe the results of this study will provide important new information, and we look forward to sharing it once obtained.
Statement:
This article is compiled based on third-party information and is intended for industry professionals' exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is solely for industry-related exchange and research.
Due to limitations in translation skills, the translated article may not fully reflect the original text. Therefore, readers should refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
